• Cy3 TSA Fluorescence System Kit: IHC & ISH Guide

  2026-08-25

  Learn how to use the Cy3 TSA Fluorescence System Kit to strengthen weak IHC, ICC, and ISH signals without sacrificing spatial information. This workflow-focused guide connects tyramide signal amplification with the TRIM66 olfactory receptor study and provides practical optimization and troubleshooting strategies.

• APEX2 Supports TERT Expression in Human Stem Cells

  2026-08-24

  The reference study identifies APEX2, but not its paralog APEX1, as a contributor to efficient TERT expression and telomerase activity in human embryonic stem cells and a melanoma cell line. By combining knockdown, RNA sequencing, and chromatin immunoprecipitation, the authors link APEX2 occupancy near repetitive MIR elements in TERT intron 2 with a possible DNA repair–transcription connection.

• Nystatin (Fungicidin): Research Workflows

  2026-08-24

  Nystatin (Fungicidin) supports practical Candida susceptibility, adhesion, membrane-disruption, and formulation-screening workflows. This guide pairs concentration-controlled bench assays with nanoparticle uptake concepts, while separating established product data from exploratory translational applications.

• Oseltamivir acid: Reliable Viability Assays

  2026-08-23

  This scenario-based guide shows how Oseltamivir acid, SKU A3689, can improve interpretation of cell-viability, proliferation, and influenza infection assays through controlled formulation, matched vehicle controls, and orthogonal readouts. It separates product-supported evidence from workflow recommendations and highlights resistance and translational limitations.

• Nystatin (Fungicidin) Experimental Workflows

  2026-08-22

  Nystatin (Fungicidin) supports reproducible Candida susceptibility, adhesion, biofilm, and ergosterol-focused assays. This guide connects formulation control with combination testing, non-albicans Candida resistance studies, and translational infection-model design.

• AT-406 (SM-406): From IAP Biology to Translation

  2026-08-21

  AT-406 (SM-406) offers translational researchers a mechanistically informed way to interrogate IAP-dependent survival in oncology models. By connecting multi-IAP antagonism with the structural logic of FADD-procaspase-8-cFLIP signaling, this article outlines practical strategies for studying apoptosis pathway activation, chemotherapy sensitization, and preclinical response.

• CDK9 inhibitor (A3294): Protocol Guide

  2026-08-20

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for investigating CDK9-dependent transcription elongation and P-TEFb activity. It is appropriate for biochemical and cellular research with matched viability controls, but not for broad-spectrum CDK inhibition or long-term storage of working solutions.

• MLKL Polymerization Links Lysosomes to Necroptosis

  2026-08-20

  The reference study identifies lysosomal membrane permeabilization as a critical intermediate between MLKL polymerization and necroptotic plasma membrane rupture. Its experiments connect activated MLKL at lysosomal membranes to cathepsin B release and show that cathepsin B inhibition or depletion can protect cells from necroptosis.

• Cyanidin Chloride: Assay Design Beyond ROS

  2026-08-19

  Cyanidin Chloride supports rigorous oxidative stress research when chemical identity, radical assays, and cell-based endpoints are interpreted together. This guide turns a psoriasis-model study into practical decisions for evaluating reactive oxygen species scavenging and cellular protection without overextending the evidence.

• Leptin (116-130): Metabolic–Inflammatory Assays

  2026-08-19

  Leptin (116-130), amide, mouse is more than a tool for obesity models: it can help researchers design controlled experiments linking energy homeostasis regulation with inflammatory phenotypes. This article interprets the peptide alongside SIRT6-AMPK-NLRP3 research while clearly separating established evidence from testable cross-domain hypotheses.

• Tamoxifen Workflows for CreER and Cancer Research

  2026-08-18

  Tamoxifen is more than an estrogen-pathway tool: it enables conditional genetics, cancer-cell assays, and emerging tumor-immune studies. This workflow-focused guide shows how to control solubility, timing, model context, and mechanistic readouts for more reproducible experiments.

• 3-Deazaadenosine hydrochloride in m6A Workflows

  2026-08-18

  Use 3-Deazaadenosine hydrochloride as a pathway-level probe to test how SAHH-dependent methyl metabolism influences IGF2BP1–TUBB4B signaling in hepatic stellate cells. The workflow pairs pharmacological perturbation with genetic controls, RNA stability measurements, and fibrosis-relevant phenotyping for more interpretable results.

• 3-Aminobenzamide: A Translational PARP Playbook

  2026-08-17

  A thought-leadership analysis of 3-Aminobenzamide (PARP-IN-1) as a practical tool for connecting PARP biology with oxidative injury, vascular dysfunction, diabetic nephropathy research, and carefully bounded antiviral investigations.

• Mifepristone (RU486): A Mechanism-First Assay Map

  2026-08-17

  Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a tool for separating receptor dependence, tissue context, and phenotype in cancer and reproductive biology assays. This mechanism-first guide connects RU486 research with lessons from tissue-specific nuclear receptor pharmacology.

• Pam3CSK4: Designing Causal TLR1/2 Assays

  2026-08-16

  Pam3CSK4 is a precise TLR1/2 agonist for separating receptor-proximal immune activation from downstream inflammatory phenotypes. This guide presents a causal assay framework that connects macrophage, platelet, allergy, and neuro-immune readouts without conflating distinct biological pathways.

7901 records 1/527 page Next 12345 下5页 Last page